USA flag logo/image

An Official Website of the United States Government

Polarized Xenon Production: Powerful Narrowed Laser

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
76234
Program Year/Program:
2007 / STTR
Agency Tracking Number:
ES014005
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
XEMED, LLC
16 Strafford Avenue DURHAM, NH -
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 2
Fiscal Year: 2007
Title: Polarized Xenon Production: Powerful Narrowed Laser
Agency: HHS
Contract: 2R42ES014005-02
Award Amount: $749,622.00
 

Abstract:

DESCRIPTION (provided by applicant): Hyperpolarized xenon and helium have both demonstrated utility in functional lung imaging and quantifying lung disease. Hyperpolarized xenon offers advantages of a low diffusion constant and availability from natural so urces. It also has applications in dissolved state imaging, with a high solubility in fluids and tissues and a characteristic chemical shift, revealing its microscopic environment. Comparison of the dissolved and gaseous signals in lungs, for example, offe rs a precise measure of surface-to-volume ratio. A protocol involving a suite of lung images in three-dimensions or a program to investigate dissolved- phase imaging of perfused organs in humans could beneficially utilize large quantities of highly polariz ed xenon. The UNH group has developed a new type of xenon polarizer that flows the gas mixture at relatively high velocity and low pressure along a direction opposite to the laser beam, producing polarization of over 60% for small quantities and 22% for a production rate of six liters per hour. The figure-of-merit (polarization times production rate) of this polarizer presently exceeds all other polarizer technologies by an order of magnitude. The 500 torr operating pressure represents a compromise between higher laser absorption (at higher pressure) and faster spin-exchange rates (at lower pressure). Our numerical simulations indicate that magnetization output scales with absorbed laser power, that is, power within a narrow range around the spectral absorpt ion band. Using STTR Phase I funding we have further developed our high-power spectrally narrowed laser technology for spin-exchange optical pumping of hyperpolarized gas. We scaled up our spectrally narrowed laser technology to 480W. Separately, we adapte d our 5 bar 130 watt and 9 bar 270 watt lasers to investigate two new technologies to reduce the mode structure of the output beam for better collimation. We recently installed our 270 watt laser on the polarizer, and we expect polarization figures for bot h lasers once calibrations are set. For Phase II we will complete our study of the mode reduction technology to achieve a narrow spectral output with nearly ideal collimation. We will measure laser output as a function of mode and spectral constraints. We will investigate polarizer output as a function of laser power. We will test two different polarizer column diameters and two different polarizer column lengths to optimize the physical properties of the polarizer for increased output. We expect to come cl ose to the goal of real-time hyperpolarized xenon production, 60 L/hr at ~50% polarization. This research to develop a high power laser will increase the production rate for producing hyperpolarized xenon. Hyperpolarized Xenon Magnetic Resonance Imaging (M RI) was recently demonstrated as an exquisitely sensitive method for assessment of lung ventilation and tissue health, with applications to quantifying obstructive lung disease and emphysema. The specific aim of the current work is to increase the producti on rate of hyperpolarized xenon to greater than 60 L/hr, allowing an imaging subject to breathe the gas directly from the polarizer in real time. High-volume, cost-effective production of hyperpolarized xenon will also provide a new background-free, non-re circulating contrast agent for blood and tissues which may offer unique contrast for diagnosing a broad spectrum of diseases.

Principal Investigator:

Jan H. Distelbrink
6038681888
JAND@PHYSICS.UNH.EDU

Business Contact:

William F. Hersman
hersman@xemed.com
Small Business Information at Submission:

XEMED, LLC
XEMED, LLC 16 Strafford Avenue DURHAM, NH 03824

EIN/Tax ID: 201331118
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Research Institution Information:
UNIVERSITY OF NEW HAMPSHIRE
UNIVERSITY OF NEW HAMPSHIRE
OFFICE OF SPONSORED RESEARCH
DURHAM, NH 3824
RI Type: Nonprofit college or university